Corvus Pharmaceuticals Cash from Financing (TTM) Analysis

Corvus Pharmaceuticals Inc (CRVS)

1.71 +0.10 (+6.21%) USD | NASDAQ | May 02, 12:48

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	7.855M
September 30, 2023	7.855M
June 30, 2023	7.52M
March 31, 2023	0.004M
December 31, 2022	0.00
September 30, 2022	0.018M
June 30, 2022	18.35M
March 31, 2022	29.57M
December 31, 2021	62.16M
September 30, 2021	63.36M
June 30, 2021	45.09M
March 31, 2021	33.90M
December 31, 2020	1.31M
September 30, 2020	0.089M
June 30, 2020	0.041M
March 31, 2020	0.023M
December 31, 2019	0.024M

Date	Value
September 30, 2019	0.194M
June 30, 2019	0.344M
March 31, 2019	0.387M
December 31, 2018	65.27M
September 30, 2018	66.41M
June 30, 2018	66.37M
March 31, 2018	66.32M
December 31, 2017	1.442M
September 30, 2017	0.137M
June 30, 2017	0.011M
March 31, 2017	7.023M
December 31, 2016	71.36M
September 30, 2016	70.63M
June 30, 2016	145.53M
March 31, 2016	155.25M
December 31, 2015	94.95M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

Minimum

Dec 2022

63.36M

Maximum

Sep 2021

14.62M

Average

1.31M

Median

Dec 2020

Cash from Financing (TTM) Benchmarks